American Portfolios Advisors Crispr Therapeutics Ag Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, American Portfolios Advisors holds 20,785 shares of CRSP stock, worth $1.12 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,785
Holding current value
$1.12 Million
% of portfolio
0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$61.1 - $83.78 $1.27 Million - $1.74 Million
20,785 New
20,785 $1.36 Billion
Q2 2022

Mar 20, 2023
SELL
$43.23 - $73.83 $39,123 - $66,816
-905 Reduced 4.35%
19,880 $1.21 Billion
Q1 2022

Mar 21, 2023
SELL
$53.19 - $79.24 $181,165 - $269,891
-3,406 Reduced 16.39%
17,379 $1.09 Billion
Q4 2021

Mar 21, 2023
SELL
$70.09 - $111.29 $353,253 - $560,901
-5,040 Reduced 24.25%
15,745 $1.19 Billion
Q3 2021

Mar 22, 2023
SELL
$110.2 - $156.64 $630,784 - $896,607
-5,724 Reduced 27.54%
15,061 $1.69 Billion
Q2 2021

Mar 22, 2023
SELL
$100.84 - $161.89 $635,897 - $1.02 Million
-6,306 Reduced 30.34%
14,479 $2.34 Billion
Q1 2021

Mar 22, 2023
SELL
$110.72 - $210.04 $651,587 - $1.24 Million
-5,885 Reduced 28.31%
14,900 $1.82 Billion
Q4 2020

Mar 22, 2023
SELL
$79.67 - $173.23 $575,376 - $1.25 Million
-7,222 Reduced 34.75%
13,563 $2.08 Billion
Q3 2020

Mar 22, 2023
SELL
$78.5 - $100.64 $859,653 - $1.1 Million
-10,951 Reduced 52.69%
9,834 $823 Million
Q2 2020

Mar 24, 2023
BUY
$38.5 - $76.05 $83,506 - $164,952
2,169 Added 52.65%
6,289 $462 Million
Q1 2020

Mar 24, 2023
SELL
$33.68 - $62.53 $561,277 - $1.04 Million
-16,665 Reduced 80.18%
4,120 $175 Million
Q4 2019

Mar 24, 2023
SELL
$36.68 - $73.13 $623,156 - $1.24 Million
-16,989 Reduced 81.74%
3,796 $231 Million
Q3 2019

Mar 24, 2023
BUY
$40.99 - $52.56 $3,033 - $3,889
74 Added 2.33%
3,256 $133 Million
Q2 2019

Mar 24, 2023
SELL
$35.45 - $48.2 $624,026 - $848,464
-17,603 Reduced 84.69%
3,182 $150 Million
Q1 2019

Mar 24, 2023
SELL
$28.02 - $40.87 $25,218 - $36,783
-900 Reduced 26.28%
2,525 $90.2 Million
Q4 2018

Mar 24, 2023
BUY
$22.73 - $42.34 $6,250 - $11,643
275 Added 8.73%
3,425 $97.9 Million
Q3 2018

Mar 24, 2023
SELL
$44.35 - $65.71 $782,112 - $1.16 Million
-17,635 Reduced 84.84%
3,150 $140 Million
Q2 2018

Mar 24, 2023
SELL
$42.62 - $73.59 $753,734 - $1.3 Million
-17,685 Reduced 85.09%
3,100 $182 Million

Others Institutions Holding CRSP

# of Institutions
549
Shares Held
56.3M
Call Options Held
2.91M
Put Options Held
2.47M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.21B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email